Latest Insider Transactions at Allakos Inc. (ALLK)
This section provides a real-time view of insider transactions for Allakos Inc. (ALLK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allakos Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allakos Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2021
|
Adam Tomasi President |
BUY
Payment of exercise price or tax liability
|
Direct |
1,717
+1.09%
|
$200,889
$117.82 P/Share
|
|
Mar 02
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.78%
|
$20,000
$1.16 P/Share
|
|
Mar 02
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-15.99%
|
$2,340,000
$117.32 P/Share
|
|
Mar 02
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,316
-1.25%
|
$153,972
$117.82 P/Share
|
|
Mar 01
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.78%
|
$20,000
$1.16 P/Share
|
|
Mar 01
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-15.99%
|
$2,400,000
$120.66 P/Share
|
|
Feb 18
2021
|
John P Mckearn Director |
BUY
Other acquisition or disposition
|
Indirect |
8,016
+48.13%
|
-
|
|
Feb 18
2021
|
John P Mckearn Director |
SELL
Other acquisition or disposition
|
Indirect |
47,494
-0.96%
|
-
|
|
Jan 04
2021
|
River Vest Venture Fund Iii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
862,574
-15.0%
|
-
|
|
Jan 04
2021
|
John P Mckearn Director |
BUY
Other acquisition or disposition
|
Indirect |
623
+50.0%
|
-
|
|
Jan 04
2021
|
John P Mckearn Director |
SELL
Other acquisition or disposition
|
Indirect |
862,574
-14.88%
|
-
|
|
Jan 04
2021
|
Alta Partners Next Gen Fund I Management, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
2,441,735
-59.51%
|
-
|
|
Jan 04
2021
|
Alta Partners Next Gen Fund I Management, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
441,735
+50.0%
|
-
|
|
Dec 31
2020
|
Paul Edward Walker |
SELL
Open market or private sale
|
Indirect |
35,023
-0.53%
|
$4,903,220
$140.55 P/Share
|
|
Dec 30
2020
|
Paul Edward Walker |
SELL
Open market or private sale
|
Indirect |
68,392
-0.76%
|
$9,711,664
$142.49 P/Share
|
|
Dec 29
2020
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,240
+3.3%
|
$32,960
$4.31 P/Share
|
|
Dec 29
2020
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,416
+3.32%
|
$21,664
$4.31 P/Share
|
|
Dec 02
2020
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,501
-5.86%
|
$1,435,599
$99.04 P/Share
|
|
Dec 02
2020
|
Mark Asbury CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,977
-4.49%
|
$294,723
$99.04 P/Share
|
|
Dec 02
2020
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,954
-3.64%
|
$391,446
$99.04 P/Share
|
|
Dec 02
2020
|
Leo Redmond Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,472
-4.54%
|
$244,728
$99.04 P/Share
|
|
Dec 02
2020
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
8,825
-5.48%
|
$873,675
$99.04 P/Share
|
|
Dec 01
2020
|
Robert Alexander Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121,600
+32.96%
|
-
|
|
Dec 01
2020
|
Mark Asbury CLO |
BUY
Grant, award, or other acquisition
|
Direct |
32,400
+32.85%
|
-
|
|
Dec 01
2020
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,300
+32.47%
|
-
|
|
Dec 01
2020
|
Leo Redmond Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,900
+33.08%
|
-
|
|
Dec 01
2020
|
Adam Tomasi President |
BUY
Grant, award, or other acquisition
|
Direct |
78,500
+32.75%
|
-
|
|
Jul 23
2018
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,009,090
+50.0%
|
-
|